Andreessen Horowitz October 19, 2020
Jorge Conde

The entire healthcare system is built around the idea that we can detect, diagnose, and manage disease effectively for patients. This pandemic has been a stress test of that capability, and we have roundly failed that test. If we can’t do those “easy” things—test for the virus, provide medical care for those that need it, even just get people the right PPE—how are we possibly going to absorb major new technologies into the system?

COVID-19 has been a massive disruption to our system. But there’s another one coming. We’re in the middle of a fundamental shift in healthcare which will require major change across the entire landscape: our increasing ability to fix the underlying cause of disease by manipulating...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Pharma / Biotech, Provider, Public Health / COVID
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article